Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 1 March 2027
- Last conf. stmt
- 15 February 2026
GW Pharmaceuticals Limited
- Incorporated
- 15 February 2001 (25 years)
- Industry
- Other human health activities (86900)
- Directors
- Amanda Flanagan
- Accounts type
- Full
- Region
- Greater London
- Address
- 80 Charlotte StreetLondonW1T 4DF
Charges
- Total
- 4
- Outstanding
- 4
- Part satisfied
- 0
- Satisfied
- 0
Officers 3 active
Officer details are public data from the Companies House register.
Flanagan, Amanda
Director · Appointed 10 February 2025
Irish
Born August 1971 (55)
Patel, Alkesh
Secretary · Appointed 3 April 2024
Director · Appointed 13 January 2023
British
Born January 1976 (50)
Officer history (33 former)
10 February 2025
Resigned Armissoglio Ép. Lepelletier, Nelly Alexandra as Director
10 February 2025
Appointed Flanagan, Amanda as Director
3 April 2024
Appointed Patel, Alkesh as Secretary
3 April 2024
Resigned Doody, Aislinn Jane as Secretary
13 January 2023
13 January 2023
13 January 2023
Appointed Doody, Aislinn Jane as Secretary
13 January 2023
Appointed Armissoglio Ép. Lepelletier, Nelly Alexandra as Director
13 January 2023
Resigned Ward, Iain as Secretary
1 January 2023
12 August 2021
Appointed Ward, Iain as Secretary
12 August 2021
Resigned Snyder, Douglas as Secretary
5 May 2021
Resigned Secor, Alicia Mary as Director
5 May 2021
Resigned Waldegrave, William Arthur, Lord as Director
5 May 2021
5 May 2021
5 May 2021
Resigned Gryska, David as Director
5 May 2021
5 May 2021
Resigned Mackey, Catherine as Director
5 May 2021
5 May 2021
5 May 2021
18 December 2020
Appointed Snyder, Douglas as Secretary
18 December 2020
9 September 2020
Appointed Gryska, David as Director
1 April 2020
Resigned Lynch, Thomas Gerard as Director
21 December 2017
Appointed Mackey, Catherine as Director
21 December 2017
Appointed Waldegrave, William Arthur, Lord as Director
21 December 2017
Appointed Secor, Alicia Mary as Director
13 February 2017
13 February 2017
13 February 2017
13 February 2017
Resigned Gangolli, Julian Steatham as Director
16 July 2015
Appointed Gangolli, Julian Steatham as Director
19 February 2013
18 January 2013
18 January 2013
18 January 2013
1 October 2012
1 June 2012
1 June 2012
27 July 2010
Appointed Lynch, Thomas Gerard as Director
27 July 2010
18 March 2008
5 March 2008
5 March 2008
20 March 2007
15 March 2007
15 March 2007
26 January 2007
9 February 2006
9 February 2006
22 March 2005
16 April 2003
10 September 2001
10 September 2001
31 May 2001
31 May 2001
5 March 2001
5 March 2001
5 March 2001
5 March 2001
5 March 2001
5 March 2001
5 March 2001
5 March 2001
15 February 2001
15 February 2001
15 February 2001
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 5 May 2021
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 13150429
Group structure 6 companies
Ownership group derived from the Companies House PSC register
GW Pharmaceuticals Limited This company Owns 75–100% of shares
Jazz Pharmaceuticals Operations UK Limited Owns 75–100% of shares
Jazz Financing UK Limited Owns 75–100% of shares
Jazz Pharmaceuticals Research UK Limited Owns 75–100% of shares
Jazz Pharmaceuticals UK Limited Owns 75–100% of shares
Filings 407
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 15 September 2026 | Full accounts | 31 December 2025 | ||
| 9 July 2026 | Registered office address changed | |||
| 9 July 2026 | Registered office address changed | |||
| 17 February 2026 | Confirmation statement with no updates | 15 February 2026 | ||
| 30 September 2025 | Full accounts | 31 December 2024 |
Some other companies at this address
Other companies in this industry
Chesterfield
Guildford
London
Westcliff-On-Sea
Leicester
London
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →